JPS643122A - Remedy for endometriosis - Google Patents

Remedy for endometriosis

Info

Publication number
JPS643122A
JPS643122A JP15803087A JP15803087A JPS643122A JP S643122 A JPS643122 A JP S643122A JP 15803087 A JP15803087 A JP 15803087A JP 15803087 A JP15803087 A JP 15803087A JP S643122 A JPS643122 A JP S643122A
Authority
JP
Japan
Prior art keywords
endometriosis
gonatriene
alkyl
active ingredient
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15803087A
Other languages
Japanese (ja)
Other versions
JPH013122A (en
Inventor
Kazumasa Nitta
Hiroaki Ueno
Norio Hirabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Tokyo Tanabe Co Ltd
Original Assignee
Mitsubishi Kasei Corp
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp, Tokyo Tanabe Co Ltd filed Critical Mitsubishi Kasei Corp
Priority to JP62-158030A priority Critical patent/JPH013122A/en
Priority claimed from JP62-158030A external-priority patent/JPH013122A/en
Publication of JPS643122A publication Critical patent/JPS643122A/en
Publication of JPH013122A publication Critical patent/JPH013122A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

PURPOSE: To obtain a remedy for endometriosis useful for treating endometriosis, suppressing production and release of pituitary gonadotropin, containing a gonatriene derivative as an active ingredient.
CONSTITUTION: A gonatriene derivative shown by the formula (R is 1W3C alkyl; X is -OR1 or -SR2; R1 and R2 are 1W3C alkyl) as an active ingredient is pharmaceutically manufactured by a conventional procedure to give the aimed substance. The substance can be prepared into powder, granule, tablet, capsule, solution, suppository, emulsion or injection and a dose is about 0.1W50mg per adult daily in the case of oral administration. The compound shown by the formula is obtained by deriving an alkoxymethyltriene from a diketone, decomposing acetal group under an acidic condition to regenerate carbonyl group at the 3-position and 17α-methoxymethyl-17β-hydroxy-13β-methyl- gona-4,9,11-trien-3-one may be cited as the compound.
COPYRIGHT: (C)1989,JPO&Japio
JP62-158030A 1987-06-25 Endometriosis treatment drug Pending JPH013122A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62-158030A JPH013122A (en) 1987-06-25 Endometriosis treatment drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62-158030A JPH013122A (en) 1987-06-25 Endometriosis treatment drug

Publications (2)

Publication Number Publication Date
JPS643122A true JPS643122A (en) 1989-01-06
JPH013122A JPH013122A (en) 1989-01-06

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652231A (en) * 1993-11-19 1997-07-29 Mochida Pharmaceutical Co., Ltd. Carcinostatic for hormonotherapy containing dienogest as effective component

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652231A (en) * 1993-11-19 1997-07-29 Mochida Pharmaceutical Co., Ltd. Carcinostatic for hormonotherapy containing dienogest as effective component

Similar Documents

Publication Publication Date Title
JPS5241214A (en) Method of making preparations for oral administration
JPS5759894A (en) Cephalosporin for oral administration
JPS5767516A (en) Novel analgesic agent
JPS643122A (en) Remedy for endometriosis
JPS6416721A (en) Antioxidant
CA1139670A (en) Process and composition for reducing blood pressure in animals
JPS643121A (en) Remedy for endometriosis
JPS55122715A (en) Antidiabetic agent
JPS5536454A (en) Novel immunosuppressive agent
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
JPS55151511A (en) Antiallergic agent consisting mainly of kynurenic ester derivative
JPS54132239A (en) Anti-tumor agent
JPS5536453A (en) Novel immunosuppressive agent
US3795736A (en) 5,5-dimethyl-10-hydroxy-8-(3-methyl-2-octyl)-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-(1) benzopyrano(3,4-d)pyridine as an analgesic agent
JPS6442425A (en) Remedy for cachexia
JPS55111470A (en) Geldanamycin derivative, its preparation, antitumor drug comprising it as active ingredient
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
JPS5569510A (en) Carcinostatic agent
JPS5742620A (en) Novel antiulcer agent
JPS57126418A (en) Antiallergic agent
JPS57128625A (en) Carcinostatic
JPS5748910A (en) Analgesic cholagogic agent
JPS54125663A (en) Carcinostatic agent and novel compound having carcinostatic activity
JPS57126422A (en) Stabilizing method of lysozyme pharmaceutical